Unique precision medicine with a dual targeting of CD8+ CXCR3+ T cells offers potential for a first-in-class targeted systemic ... Unique potential as a first-in-class, oral, targeted systemic therapy ...

Presentation to take place on January 15, 2025, at 15:00 PST / 00:00 CET and will be available for replay on demand Idorsia Ltd (SIX: IDIA) today announced that André C. Muller, Chief Executive ...

1 Department of Targeting Therapy and Immunology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China 2 Division of Thoracic Tumor Multimodality Treatment, Cancer Center, ...

Ki-67 staining, a scratch experiment, real-time PCR, and Western blotting were used to explore the effect of the Th17 cell supernatant on keloid fibroblasts. Results: Our findings revealed the ...